Literature DB >> 17606456

Blood transfusion requirements for patients undergoing chemotherapy for acute myeloid leukemia how much is enough?

Mark A Dawson1, Sharon Avery, Zoe K McQuilten, Michael J Bailey, Jake Shortt, Mark N Polizzotto, Erica M Wood, Merrole F Cole-Sinclair.   

Abstract

Although essential in the management of AML, there is little information quantitating transfusion requirements for these patients. We evaluated 111 consecutive adults treated for AML, showing that approximately 150 blood donors are required to adequately cater for a single patient's complete therapy with little variation for age, prognostic group or intensity of treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17606456     DOI: 10.3324/haematol.11019

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  3 in total

1.  Single versus double-unit transfusion: Safety and efficacy for patients with hematologic malignancies.

Authors:  Zelia Bowman; Naomi Fei; Janice Ahn; Sijin Wen; Aaron Cumpston; Nilay Shah; Michael Craig; Peter L Perrotta; Abraham S Kanate
Journal:  Eur J Haematol       Date:  2019-02-25       Impact factor: 2.997

2.  A Jehovah's Witness with Acute Myeloid Leukemia Successfully Treated with an Epigenetic Drug, Azacitidine: A Clue for Development of Anti-AML Therapy Requiring Minimum Blood Transfusions.

Authors:  Yumi Yamamoto; Akihito Kawashima; Eri Kashiwagi; Kiyoyuki Ogata
Journal:  Case Rep Hematol       Date:  2014-10-02

3.  Outcome of acute myeloid leukaemia in Nigeria: clinician's perspective.

Authors:  Ann Abiola Ogbenna; Olufemi Abiola Oyedeji; Christiana Oluwakemi Famuyiwa; Babajide Ayodeji Sopekan; Obadiah Dapus Damulak; Esere Bernice Akpatason; Gbenga Olorunfemi; Kehinde Adekola
Journal:  Ecancermedicalscience       Date:  2021-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.